Information Journal Paper
APA:
Copy. (2018). Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. CLIN EPIGENETICS, 10(-), 0-0. SID. https://sid.ir/paper/693115/en
Vancouver:
Copy. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. CLIN EPIGENETICS[Internet]. 2018;10(-):0-0. Available from: https://sid.ir/paper/693115/en
IEEE:
Copy, “Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage,” CLIN EPIGENETICS, vol. 10, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/693115/en